03Recent Activity
Participated in Variational's $50M Series A for on-chain derivatives infrastructure.
MAY 20, 2026
Led Variational's approximately $50M Series A for on-chain derivatives and real-world asset markets.
MAY 20, 2026
Variational AI is pioneering a new era of small molecule drug discovery by leveraging generative AI to redefine the unit economics of drug discovery, enabling biopharma partners to bring novel therapeutics to patients faster and more cost-effectively
Variational AI is pioneering a new era of small molecule drug discovery by leveraging generative AI to redefine the unit economics of drug discovery, enabling biopharma partners to bring novel therapeutics to patients faster and more cost-effectively.